Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aerie's Rhopressa Approved Early For Glaucoma, 2018 Launch Planned

Dec 20 2017

• By Mandy Jackson

Close-up of blue eye. High Technologies in the futuristic. : cataract

Related Content

Aerie's M&A Potential Rises As Roclatan Passes Second Phase III Glaucoma Test

May 26 2017

Aerie's Netarsudil's Safety Questions May Determine Fate At Advisory Committee

Oct 12 2017

Aerie's Netarsudil Headed For Broad Indication With Only Subpopulation Efficacy

Oct 15 2017

Related Companies

Aerie Pharmaceuticals, Inc.

Pfizer Inc.

Novartis AG

Additional Topics

Approvals Business Strategies Commercial Ophthalmic BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window